Tom Lounibos
Global Managing Director @ Accenture Ventures
San Francisco, United States
Tom Lounibos is a Series A investor at Accenture Ventures in San Francisco focused on Software and Artificial Intelligence. Tom Lounibos is the Global Managing Director of Accenture Ventures
- Total investments:
- 42
- Last investment:
- Lead investor:
- 69%
Last updated:
For AI agents: llms.txt
Industries Tom Lounibos invests in
Stages Tom Lounibos invests in
Countries Tom Lounibos invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 14 (33%)
- Artificial Intelligence 10 (24%)
- Information Technology 8 (19%)
- Enterprise Software 6 (14%)
- Analytics 5 (12%)
Stage
- Series A 10 (24%)
- Seed 9 (21%)
- Venture - Series Unknown 9 (21%)
- Funding Round 8 (19%)
- Series B 3 (7%)
Country
- United States 23 (55%)
- United Kingdom 3 (7%)
- Canada 2 (5%)
- France 2 (5%)
- Israel 2 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CLIKA is a software company that develops optimization tools to streamline the execution of artificial intelligence projects. The company provides an AI compression platform that enables compact, accelerated, and hardware-ready deployment—across cloud, on-prem, and edge environments. | Seed / Aug 21, 2025 | ||
| GoUpscale is a technology company that offers sales engagement solutions. GoUpscale's technology addresses the challenges faced by organizations in the financial service industry in creating compelling content. GoUpscale's solutions are designed to enhance content engagement and relationship management, thereby transforming sales andcontent engagement processes. | Seed / Apr 14, 2025 | ||
| 1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development. The company establishes an understanding of the molecular basis of disease to the granularity at which the world understands sickle cell anemia. This understanding drives their integration of artificial intelligence (AI),computation, and biological automation to accelerate the design of small molecule and protein therapeutics. | Venture - Series Unknown / Oct 31, 2024 | ||
| Earli is a developer of cancer treatment devices designed to search for natural biomarkers. The company's mission is to make cancer a benign experience. Cancers are detected early when they are homogeneous; and then located early, so they can be treated when the chances of survival are multiple times higher. Rather than rely on biomarkers thatcancer may - or often may not - naturally provide, Earli's technology forces cancer cells to make a synthetic, non-human biomarker using a novel gene therapy approach called Synthetic Biopsy. The early cancer is then visible in a PET scanner. The same platform is also usable for therapeutics. | Venture - Series Unknown / Aug 19, 2024 | ||
| Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer. | Venture - Series Unknown / May 16, 2024 | ||
| Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services. | $2M / Series A / Jan 08, 2024 | ||
| Aliro Quantum, The Quantum Networking Company™, offers AliroNet™ to emulate, pilot, and deploy entanglement-based quantum networks that are capable of running a wide variety of applications from secure communications to clustered quantum computing and distributed quantum sensing. Aliro, spun out of NarangLab at Harvard University, includesworld-class experts in quantum and classical networking and is leading the charge in quantum network development by offering the foundational technologies needed for organizations around the world to build scalable and powerful distributed quantum systems. AliroNet™ users include utility companies, telecommunications providers, public sector organizations, enterprises, and researchers who are simulating, designing, piloting, orchestrating, and building the world's first entanglement-based quantum networks.Aliro also works with industry and academic partners through the Quantum Economic Development Consortium (QED-C), the NSF Center for Quantum Networks (CQN), and the NSF Quantum Leap Challenge Institute Hybrid Quantum Architectures and Networks (HQAN). Additionally, Aliro is involved in several quantum networking standards groups at IEEE and QED-C. | $6M / Oct 10, 2023 | ||
| Aliro Quantum, The Quantum Networking Company™, offers AliroNet™ to emulate, pilot, and deploy entanglement-based quantum networks that are capable of running a wide variety of applications from secure communications to clustered quantum computing and distributed quantum sensing. Aliro, spun out of NarangLab at Harvard University, includesworld-class experts in quantum and classical networking and is leading the charge in quantum network development by offering the foundational technologies needed for organizations around the world to build scalable and powerful distributed quantum systems. AliroNet™ users include utility companies, telecommunications providers, public sector organizations, enterprises, and researchers who are simulating, designing, piloting, orchestrating, and building the world's first entanglement-based quantum networks.Aliro also works with industry and academic partners through the Quantum Economic Development Consortium (QED-C), the NSF Center for Quantum Networks (CQN), and the NSF Quantum Leap Challenge Institute Hybrid Quantum Architectures and Networks (HQAN). Additionally, Aliro is involved in several quantum networking standards groups at IEEE and QED-C. | $9.1M / Series A / Oct 10, 2023 | ||
| Open Cosmos is a space technology company that designs, builds, and operates satellites to simplify access to space. The company also delivers end-to-end telecommunications, Earth Observation (EO), navigation, and scientific missions. It designs, builds, launches and operates advanced satellites through its OpenOrbit offering, that enablesorganizations to access and share data via its mutualized OpenConstellation infrastructure and offers AI-powered data analysis from a growing range of satellite sources and analytic partners through its DataCosmos platform. | $50M / Series B / Sep 11, 2023 | ||
| Stardog, the leading Enterprise Knowledge Graph platform, turns data into knowledge to power more effective digital transformations. Industry leaders including Bosch, Ericsson, BNY Mellon, NASA and the NIH use Stardog to create a flexible data layer that can support countless applications. Stardog is a privately held, venture-backed companyheadquartered in Arlington, VA. It is ranked as one of Fast Company’s most Innovative Companies of 2020. For more information, please visit www.stardog.com. | Venture - Series Unknown / May 10, 2023 | ||
| See all 42 investments → | |||
Co-Investors
About Accenture Ventures
Accenture Ventures partners with growth-stage startups that create innovative and disruptive enterprise technologies using an open innovation.
Accenture Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Tom Lounibos
Global Managing Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Tom Lounibos invest in?
Tom Lounibos invests primarily in Software, Artificial Intelligence and Information Technology startups, most often at Series A and Seed stage. Most of the 42 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Tom Lounibos?
Public channels for Tom Lounibos include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Tom Lounibos last invest?
The most recent investment recorded for Tom Lounibos closed in Aug 2025. Shizune tracks 42 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
